Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 30,277Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Jakavi

PharmaCompass

01

Brand Name : Jakavi

Ruxolitinib

arrow
The Generic Rx Session
Not Confirmed

Brand Name : Jakavi

arrow
The Generic Rx Session
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,339

2019 Revenue in Millions : 1,114

Growth (%) : 20

blank

02

Brand Name : Jakavi

Ruxolitinib

arrow
BioAsia
Not Confirmed

03

Brand Name : Jakavi

Ruxolitinib

arrow
BioAsia
Not Confirmed

04

Brand Name : Jakavi

Ruxolitinib

arrow
BioAsia
Not Confirmed

05

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
BioAsia
Not Confirmed

06

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
BioAsia
Not Confirmed

07

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
BioAsia
Not Confirmed

08

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
BioAsia
Not Confirmed

09

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
PharmScience R&D
Not Confirmed

10

Brand Name : Jakavi

Ruxolitinib

arrow
PharmScience R&D
Not Confirmed

Brand Name : Jakavi

arrow
PharmScience R&D
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 1,114

2018 Revenue in Millions : 977

Growth (%) : 14

blank